ACOR
Acorda Therapeutics, Inc.
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
15 hedge funds and large institutions have $2.35M invested in Acorda Therapeutics, Inc. in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$35.5K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$4.5K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$163K |
| 4 |
4
Bank of America
Charlotte,
North Carolina
|
$754 |
| 5 |
5
Wells Fargo
San Francisco,
California
|
$56.5K |
